Agbonesa, Mark Jay T.

HRN: 21-32-49  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/10/2022
05/16/2022
IV
350
Q6 For 7 Days
For Pneumonia
Waiting Final Action 
05/11/2022
CEFTRIAXONE 1G (VIAL)
05/11/2022
05/17/2022
IV DRIP
700mg
OD
ALL
Waiting Final Action 
05/11/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/11/2022
05/17/2022
IVT
115mg
Q8
ALL
Waiting Final Action 
05/12/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/12/2022
05/18/2022
ORAL
4ml
TID For 7days
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: